Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by VIVEK SUBBIAH and GILBERT COTE.
VIVEK SUBBIAH
Connection Strength
0.994
GILBERT COTE
  1. Advances in Targeting RET-Dependent Cancers. Cancer Discov. 2020 04; 10(4):498-505.
    View in: PubMed
    Score: 0.711
  2. Hallmarks of RET and Co-occuring Genomic Alterations in RET-aberrant Cancers. Mol Cancer Ther. 2021 10; 20(10):1769-1776.
    View in: PubMed
    Score: 0.198
  3. Novel use of a Clinical Laboratory Improvements Amendments (CLIA)-certified Cyclin-Dependent Kinase N2C (CDKN2C) loss assay in?sporadic medullary thyroid carcinoma. Surgery. 2020 01; 167(1):80-86.
    View in: PubMed
    Score: 0.043
  4. Circulating BRAF V600E Cell-Free DNA as a Biomarker in the Management of Anaplastic Thyroid Carcinoma. JCO Precis Oncol. 2018 Dec; 2.
    View in: PubMed
    Score: 0.041
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.